询 单
请 填 写 相 关 信 息
产品信息
产品名称
别名
CAS号
结构式 上传
联系方式
公司
联系人
电话
邮箱
内容
提交
中文版 English
请输入产品名称、CAS式、分子式
Sulphur Blue 7 | CAS:1327-57-7
Sulphur Blue 7
  • 名称:硫化蓝 7 | Sulphur Blue 7
  • CAS号:1327-57-7
  • 别名:Acco Sulfur Blue 2R-CF; Acco Sulfur Blue 4R-CF; Acco Sulfur Blue 6R-CF; Acco Sulfur Blue B-CF; Acco Sulfur Blue GLP-CF; Acco Sulfur Blue GLR-CF; Acco Sulfur Blue R-CF; Asathio Blue 3B; Atul Sulfur Navy Blue; C.I. 53440
  • 分子式:
  • 分子量:
  • EINESC号:215-483-5

产品描述

物理化学性质

没有数据没有数据

安全数据

没有数据没有数据

SDS

来源 SDS样本
没有数据没有数据
产品合成路线
更多

名称 CAS号
更多
文章
同行评议文献
The pharmacokinetics and pharmacodynamics of Implanon, a single-rod etonogestrel contraceptive implant.H J Bennink The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception, 5 Suppl 2, 12-20 (2001-03-15) A multicenter randomized clinical trial of one-rod etonogestrel and two-rod levonorgestrel contraceptive implants with nonrandomized copper-IUD controls: methodology and insertion data.Olav Meirik et al.Contraception, 87(1), 113-120 (2012-10-16) Recent combined hormonal contraceptives (CHCs) and the risk of thromboembolism and other cardiovascular events in new users.Stephen Sidney et al.Contraception, 87(1), 93-100 (2012-10-23) Nexplanon, a radiopaque etonogestrel implant in combination with a next-generation applicator: 3-year results of a noncomparative multicenter trial.Ellen Mommers et al.American journal of obstetrics and gynecology, 207(5), 388-388 (2012-09-04) Early implant removal: an ethical dilemma.Sarwat Bari et al.The journal of family planning and reproductive health care, 39(1), 64-64 (2013-01-09) Newer non-oral hormonal contraception.Deborah Bateson et al.BMJ (Clinical research ed.), 346, f341-f341 (2013-02-16) Preventing repeat pregnancy in adolescents: is immediate postpartum insertion of the contraceptive implant cost effective?Leo Han et al.American journal of obstetrics and gynecology, 211(1), 24-24 (2014-03-19) Pharmacokinetics and ovarian suppression during use of a contraceptive vaginal ring in normal-weight and obese women.Carolyn L Westhoff et al.American journal of obstetrics and gynecology, 207(1), 39-39 (2012-06-26) The impact of extended-cycle vaginal ring contraception on migraine aura: a retrospective case series.Anne Calhoun et al.Headache, 52(8), 1246-1253 (2012-07-14) Determination of optimal imaging mode for ultrasonographic detection of subdermal contraceptive rods: comparison of spatial compound, conventional, and tissue harmonic imaging methods.Sungjun Kim et al.Korean journal of radiology, 13(5), 602-609 (2012-09-15) Committee opinion no. 539: adolescents and long-acting reversible contraception: implants and intrauterine devices. Obstetrics and gynecology, 120(4), 983-988 (2012-09-22) Antimüllerian hormone levels decrease in women using combined contraception independently of administration route.Sanna Kallio et al.Fertility and sterility, 99(5), 1305-1310 (2012-12-25) In brief: etonogestrel (nexplanon) contraceptive implant. The Medical letter on drugs and therapeutics, 54(1383), 12-12 (2012-02-23) Differences in prescription rates and odds ratios of antidepressant drugs in relation to individual hormonal contraceptives: a nationwide population-based study with age-specific analyses.Malou Lindberg et al.The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception, 17(2), 106-118 (2012-03-06) Pharmacokinetics of etonogestrel released from the contraceptive implant ImplanonWenzl R, et al. Contraception, 58(5), 283-288 (1998) Pharmacokinetics of the etonogestrel contraceptive implant in obese women.Sara Mornar et al.American journal of obstetrics and gynecology, 207(2), 110-110 (2012-06-22) Time dependent influence of etonogestrel on the caspase-3 immunoreactivity and apoptotic indexes of rat uterus and ovaries.Nicel Tasdemir et al.Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 28(6), 463-467 (2012-05-15) Rapid repeat pregnancy in adolescents: do immediate postpartum contraceptive implants make a difference?Kristina M Tocce et al.American journal of obstetrics and gynecology, 206(6), 481-481 (2012-05-29) Bioequivalence and x-ray visibility of a radiopaque etonogestrel implant versus a non-radiopaque implant: a 3-year, randomized, double-blind study.Peter Schnabel et al.Clinical drug investigation, 32(6), 413-422 (2012-05-01) [Reversible long-duration contraceptives: an efficient strategy to reduce non-planned pregnancies].Josefina Lira-Plascencia et al.Ginecologia y obstetricia de Mexico, 81(9), 530-540 (2013-11-06) Provision of no-cost, long-acting contraception and teenage pregnancy.Gina M Secura et al.The New England journal of medicine, 371(14), 1316-1323 (2014-10-02) Effects of the etonogestrel-releasing contraceptive implant inserted immediately postpartum on maternal hemostasis: a randomized controlled trial.Milena B Brito et al.Thrombosis research, 130(3), 355-360 (2012-05-01) Contraceptive failure rates of etonogestrel subdermal implants in overweight and obese women.Hanna Xu et al.Obstetrics and gynecology, 120(1), 21-26 (2012-06-09) Etonogestrel implant (Implanon) for contraception. Drug and therapeutics bulletin, 39(8), 57-59 (2001-08-31) Continuing need for and provision of a service for non-standard implant removal.Mary Pillai et al.The journal of family planning and reproductive health care, 40(2), 126-132 (2013-10-02) The effects of hormonal contraceptives on female sexuality: a review.Lara J Burrows et al.The journal of sexual medicine, 9(9), 2213-2223 (2012-07-14) Allergy to nexplanon®.Martin J Sullivan The journal of family planning and reproductive health care, 38(4), 272-272 (2012-10-03) Effect of progestins on immunity: medroxyprogesterone but not norethisterone or levonorgestrel suppresses the function of T cells and pDCs.Richard P H Huijbregts et al.Contraception, 90(2), 123-129 (2014-03-29) Neuropathy associated with etonogestrel implant insertion.Matthew Brown et al.Contraception, 86(5), 591-593 (2012-07-10) Embryo retrieval after hormonal treatment to control ovarian function and non-surgical artificial insemination in African lions (Panthera leo).F Goeritz et al.Reproduction in domestic animals = Zuchthygiene, 47 Suppl 6, 156-160 (2013-01-04) Easy method for Implanon removal.Vaniya Nanu Kandiyil The journal of family planning and reproductive health care, 38(3), 207-208 (2012-07-13) Effect of antiretroviral therapy including lopinavir/ritonavir or efavirenz on etonogestrel-releasing implant pharmacokinetics in HIV-positive women.Carolina S Vieira et al.Journal of acquired immune deficiency syndromes (1999), 66(4), 378-385 (2014-05-07) The combined etonogestrel/ethinyl estradiol contraceptive vaginal ring.Marie-Soleil Wagner et al.Expert opinion on pharmacotherapy, 8(11), 1769-1777 (2007-08-10) Medical eligibility criteria for new contraceptive methods: combined hormonal patch, combined hormonal vaginal ring and the etonogestrel implant.Mary E Gaffield et al.Contraception, 73(2), 134-144 (2006-01-18) Association of body mass index with removal of etonogestrel subdermal implant.Petra M Casey et al.Contraception, 87(3), 370-374 (2012-09-11) The broken (fractured) Implanon.Laura Myrick et al.The Journal of the Oklahoma State Medical Association, 105(10), 394-395 (2013-01-16) Endometrial effects of etonogestrel (Implanon) contraceptive implant.R Varma et al.Current opinion in obstetrics & gynecology, 13(3), 335-341 (2001-06-09) The management of unacceptable bleeding patterns in etonogestrel-releasing contraceptive implant users.Diana Mansour et al.Contraception, 83(3), 202-210 (2011-02-12) Continuation of the etonogestrel implant in women undergoing immediate postabortion placement.Tessa Madden et al.Obstetrics and gynecology, 120(5), 1053-1059 (2012-10-24)
备注

Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.

Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).

名称 CAS号

相关产品

相关资讯

热门标签
询 单
请 填 写 相 关 信 息
产品信息
产品名称
别名
CAS号
结构式 上传
联系方式
公司
联系人
电话
邮箱
内容
提交